144 related articles for article (PubMed ID: 22334458)
1. A new paradigm for funding medical research.
Klein R
Stem Cells; 2012 Mar; 30(3):360-2. PubMed ID: 22334458
[No Abstract] [Full Text] [Related]
2. State stem cell agency floats idea of $70 million 'Alpha' clinics.
Dolgin E
Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
[No Abstract] [Full Text] [Related]
3. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
4. California prepares to roll out stem-cell funding.
Dalton R
Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
[No Abstract] [Full Text] [Related]
5. California's vote to revive controversial stem-cell institute sparks debate.
Subbaraman N
Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
[No Abstract] [Full Text] [Related]
6. California institute for regenerative medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells; 2012 Mar; 30(3):357-9. PubMed ID: 22334457
[No Abstract] [Full Text] [Related]
7. Why regenerative stem cell medicine progresses slower than expected.
Rosemann A
J Cell Biochem; 2014 Dec; 115(12):2073-6. PubMed ID: 25079695
[No Abstract] [Full Text] [Related]
8. Local and global returns from research in stem cells: the case of the California Institute for Regenerative Medicine.
Alberro J
Regen Med; 2012 Jul; 7(4):605-13. PubMed ID: 22817632
[TBL] [Abstract][Full Text] [Related]
9. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
Servick K
Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
[No Abstract] [Full Text] [Related]
10. California: 'the Stem Cell State'. Interview with Jonathan Thomas.
Thomas J
Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272
[TBL] [Abstract][Full Text] [Related]
11. Stem-cell researcher's move attracts funding.
Check E
Nature; 2007 Jul; 448(7152):398. PubMed ID: 17653156
[No Abstract] [Full Text] [Related]
12. Stem cells on the ballot.
Goldstein LSB; Klein RN
Science; 2021 Jan; 371(6526):215. PubMed ID: 33446531
[No Abstract] [Full Text] [Related]
13. Global update: USA.
Matthews KR; Rowland ML
Regen Med; 2012 Nov; 7(6 Suppl):126-9. PubMed ID: 23210825
[TBL] [Abstract][Full Text] [Related]
14. The international translational regenerative medicine center.
Alexis Mde V; Grinnemo KH; Jove R
Regen Med; 2012 Nov; 7(6 Suppl):74-5. PubMed ID: 23210815
[TBL] [Abstract][Full Text] [Related]
15. Fighting for stem cell research. Interview with Don C Reed.
Reed DC
Regen Med; 2011 Nov; 6(6 Suppl):118-20. PubMed ID: 21999273
[TBL] [Abstract][Full Text] [Related]
16. CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
Weissman IL; Watt FM
Cell Stem Cell; 2016 Jul; 19(1):19-22. PubMed ID: 27392224
[TBL] [Abstract][Full Text] [Related]
17. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Johnson S
Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
[No Abstract] [Full Text] [Related]
18. California dreaming? A new start for regenerative medicine in the Golden State. Interview with Dr. Zach Hall.
Hall ZW
Regen Med; 2007 Jan; 2(1):25-8. PubMed ID: 17465772
[TBL] [Abstract][Full Text] [Related]
19. Stem-cell research: after the gold rush.
Aldhous P
Nature; 2005 Apr; 434(7034):694-6. PubMed ID: 15815600
[No Abstract] [Full Text] [Related]
20. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
